During the past decade, Allergy & Asthma Centre of Dayton conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allergy & Asthma Centre of Dayton" are "Asthma" (2 trials) and "Hereditary Angioedema" (1 trials). Many other conditions were trialed in "Allergy & Asthma Centre of Dayton" in a lesser frequency.

Most popular intervention types in "Allergy & Asthma Centre of Dayton" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "C1 esterase inhibitor [human] (C1INH-nf)" (1 trials), "Lebrikizumab" (1 trials), "Omalizumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy & Asthma Centre of Dayton" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Allergy & Asthma Centre of Dayton". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Allergy & Asthma Centre of Dayton, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy & Asthma Centre of Dayton, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".